Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Schedule of meet
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Akums Drugs and Pharmaceuticals Limited has scheduled an investor/analyst conference call on May 18, 2026 at 12:00 PM IST to discuss Q4 results and audited financials for FY2026. The virtual group meet will be attended by Managing Directors Mr. Sanjeev Jain and Mr. Sandeep Jain, CFO Mr. Sumeet Sood, and Head of Strategy Mr. Sahil Maheshwari. The call is being hosted by ICICI Securities with dial-in details provided for international participants. The company has explicitly stated that no unpublished price sensitive information will be shared during the meet, as required under SEBI regulations.
This is a routine regulatory disclosure indicating the company is communicating Q4 and FY2026 financial results to investors and analysts. The explicit no-UPSI statement is standard compliance practice and reassures that no market-moving information will be released during the call.